BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32237253)

  • 1. Reciprocal expression of trefoil factor-1 and thyroid transcription factor-1 in lung adenocarcinomas.
    Matsubara D; Yoshimoto T; Soda M; Amano Y; Kihara A; Funaki T; Ito T; Sakuma Y; Shibano T; Endo S; Hagiwara K; Ishikawa S; Fukayama M; Murakami Y; Mano H; Niki T
    Cancer Sci; 2020 Jun; 111(6):2183-2195. PubMed ID: 32237253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.
    Matsubara D; Soda M; Yoshimoto T; Amano Y; Sakuma Y; Yamato A; Ueno T; Kojima S; Shibano T; Hosono Y; Kawazu M; Yamashita Y; Endo S; Hagiwara K; Fukayama M; Takahashi T; Mano H; Niki T
    Cancer Sci; 2017 Sep; 108(9):1888-1896. PubMed ID: 28677170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
    Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
    Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
    Kim M; Chung YS; Kim KA; Shim HS
    Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC5AC and MUC5B enhance the characterization of mucinous adenocarcinomas of the lung and predict poor prognosis.
    Kim YK; Shin DH; Kim KB; Shin N; Park WY; Lee JH; Choi KU; Kim JY; Lee CH; Sol MY; Kim MH
    Histopathology; 2015 Oct; 67(4):520-8. PubMed ID: 25786562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features.
    Kawai H; Miura T; Kawamatsu N; Nakagawa T; Shiba-Ishii A; Yoshimoto T; Amano Y; Kihara A; Sakuma Y; Fujita K; Shibano T; Ishikawa S; Ushiku T; Fukayama M; Tsubochi H; Endo S; Hagiwara K; Matsubara D; Niki T
    Virchows Arch; 2024 May; ():. PubMed ID: 38710944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis.
    Rodriguez EF; VandenBussche CJ; Chowsilpa S; Maleki Z
    Cancer Cytopathol; 2018 Oct; 126(10):853-859. PubMed ID: 30199148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
    Dong Y; Zhou L; Zhao D; Li K; Liu Z; Che N; Liu H
    Jpn J Clin Oncol; 2020 Jun; 50(6):701-711. PubMed ID: 32083303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription start site-level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance.
    Sano K; Hayashi T; Suehara Y; Hosoya M; Takamochi K; Kohsaka S; Kishikawa S; Kishi M; Saito S; Takahashi F; Kaneko K; Suzuki K; Yao T; Ishijima M; Saito T
    J Pathol Clin Res; 2021 Jul; 7(4):361-374. PubMed ID: 34014042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
    Schilsky JB; Ni A; Ahn L; Datta S; Travis WD; Kris MG; Chaft JE; Rekhtman N; Hellmann MD
    Lung Cancer; 2017 Jun; 108():205-211. PubMed ID: 28625636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological, Radiological, and Molecular Features of Primary Lung Adenocarcinoma with Morule-Like Components.
    Wang LL; Ding L; Zhao P; Guan JJ; Ji XB; Zhou XL; Shao SH; Zou YW; Fu WW; Lin DL
    Dis Markers; 2021; 2021():9186056. PubMed ID: 34234879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.
    Oktay E; Oflazoglu U; Varol Y; Tanriverdi O; Mermur N; Arda HU; Demir L; Keskin O; Ahmadli T; Somali I; Oztop I; Meydan N
    J Cancer Res Ther; 2020; 16(4):737-744. PubMed ID: 32930112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study].
    Liu B; Wu N; Shen Q; Shi SS; Zhang SS; Ru Y; Rao Q; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):603-608. PubMed ID: 30107665
    [No Abstract]   [Full Text] [Related]  

  • 17. Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.
    Jurmeister P; Vollbrecht C; Behnke A; Frost N; Arnold A; Treue D; Rückert JC; Neudecker J; Schweizer L; Klauschen F; Horst D; Hummel M; Dietel M; von Laffert M
    Lung Cancer; 2019 Dec; 138():43-51. PubMed ID: 31634654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
    Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
    Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucinous lung adenocarcinoma, particularly referring to EGFR-mutated mucinous adenocarcinoma.
    Wakejima R; Inamura K; Ninomiya H; Nagano H; Mun M; Okumura S; Okubo K; Ishikawa Y
    Pathol Int; 2020 Feb; 70(2):72-83. PubMed ID: 31859434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subpopulation of airway epithelial cells that express hepatocyte nuclear factor 4α - its implication in the development of non-terminal respiratory unit-type lung adenocarcinoma.
    Okudela K; Arai H; Kitamura H; Baba T; Mitsui H; Suzuki T; Sugiyama M; Honda E; Matsumura M; Takemura T; Kataoka T; Koike C; Tateshi Y; Tajiri M; Ogura T; Ohashi K
    Histol Histopathol; 2019 Nov; 34(11):1217-1227. PubMed ID: 30848476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.